Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients.

N Jabri; D S Schalch; S L Schwartz; J S Fischer; M S Kipnes; B J Radnik; N J Turman; V S Marcsisin; H P Guler

doi:10.2337/diab.43.3.369

Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients.

Identifier:nobleid.org/w1/20260515/2EED8B98

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2EED8B98.svg?ark=w1%2F20260515%2F2EED8B98)](https://nobleid.org/work/w1/20260515/2EED8B98)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients.

Identifier:nobleid.org/w1/20260515/2EED8B98

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2EED8B98.svg?ark=w1%2F20260515%2F2EED8B98)](https://nobleid.org/work/w1/20260515/2EED8B98)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work